BriaCell Therapeutics Corp. (BCTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Loading interactive chart...
- Simply Wall St.
We're Hopeful That BriaCell Therapeutics (TSE:BCT) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. Indeed, BriaCell Therapeutics...
- Baystreet
Stocks in play: BriaCell Therapeutics Corp.
Announced that the U.S. Food and Drug Administration has granted Fast Track status to BriaCell’s lead ...
- GlobeNewswire
BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy
U.S. Food and Drug Administration (FDA) has granted Fast Track status to BriaCell’s lead candidate, Bria-IMT™, for the treatment of metastatic breast cancer.Fast Track improves the speed and frequency of communication with FDA, potentially leading to earlier drug approval and access by patients.BriaCell is currently enrolling and dosing advanced breast cancer patients in a Phase I/IIa study, now with Fast Track designation. PHILADELPHIA and VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWS
